Infliximab eye drops after first corneal transplant
Part of Eyes & vision clinical trials.
This trial tests infliximab—given as eye drops—after a first corneal transplant to see if it can improve healing and eye outcomes. It may help people at risk of inflammation after surgery, but it also requires careful screening for infection and medication safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- This is your first corneal transplant surgery
- You (or a caregiver) can give the eye drops and follow study instructions
- You have no active infection in or around the eye
- You do not have certain serious conditions like advanced glaucoma, major macular disease, or past corneal transplants
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an eye drop containing infliximab (a drug that blocks inflammation) can safely reduce severe dry eye symptoms caused by Sjögren's syndrome, and it also looks at how well the drug works.
This trial tests a drug called Humira (adalimumab) given as an injection under the eye during artificial cornea surgery. The drug may help reduce inflammation and improve the chance of success for this complex procedure.
This study tests whether anti-inflammatory eye drops (nepafenac, an NSAID) can help reduce swelling in the macula (the sharp-vision part of the eye) after certain cornea transplant surgeries. It compares outcomes in adults having DSAEK or DMEK who can safely use the study drops.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
This trial tests a new eye drop (tacrolimus) to treat non-infectious anterior uveitis, an inflammation in the front part of the eye. It may help reduce the need for steroid eye drops.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
Hear when a new Glaucoma Following Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.